2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow Cetuximab + mFOLFOX6: new trials by email Literature Review of Cetuximab + mFOLFOX6 trials Research Report on Cetuximab + mFOLFOX6
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer VS-7375, cetuximab, panitumumab - Colorectal Cancer | Phase 2 | Recruiting | Verastem, Inc. | 150 | 2026-07-28 | 2026-10-26 |
| Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6 - Metastatic Colorectal Cancer | Phase 2 | Recruiting | Sun Yat-sen University | 198 | 2023-11-09 | 2025-12-17 |
Sun Yat-sen University (1) · Verastem, Inc. (1)
Australia (1) · China (1) · United States (1)